Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder

2024-9-12

Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia

2024-9-6

Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets

2024-8-30

Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment

2024-8-28

Genetic factors, risk prediction and AI application of thrombotic diseases

2024-8-27

Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China

2024-8-24

Current and future therapies for follicular lymphoma

2024-8-22

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer

2024-8-19

Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder

2024-8-19

Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes

2024-8-16

M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis

2024-8-13

Hematopoietic stem/progenitor cell transplantation recovers immune defects and prevents lymphomas in Atm-deficient mice

2024-8-6

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies

2024-8-6

Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients

2024-8-6

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities

2024-8-5

Cell membrane patches transfer CAR molecules from a cellular depot to conventional T cells for constructing innovative fused-CAR-T cells without necessitating genetic modification

2024-8-5

The next frontier in immunotherapy: potential and challenges of CAR-macrophages

2024-8-5

Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment

2024-8-5

Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinoma

2024-8-5

CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy

2024-8-5

1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival

2024-8-1

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside

2024-8-1

Exploring whether ChatGPT-4 with image analysis capabilities can diagnose osteosarcoma from X-ray images

2024-7-27

Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers

2024-7-26

CAR-T cell combination therapies in hematologic malignancies

2024-7-18

Versatile function of NF-ĸB in inflammation and cancer

2024-7-16

Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion

2024-7-11

Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

2024-7-10

HIV associated lymphoma: latest updates from 2023 ASH annual meeting

2024-7-5

Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression

2024-7-1

cGAS-ISG15-RAGE axis reprogram necroptotic microenvironment and promote lymphatic metastasis in head and neck cancer

2024-6-26

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases

2024-6-18

Reconstructed colorectal cancer model to dissect the anti-tumor effect of mesenchymal stromal cells derived extracellular vesicles

2024-6-18

Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study

2024-6-12

High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma

2024-6-3

Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion

2024-5-31

Advances in nano-immunotherapy for hematological malignancies

2024-5-25

Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells

2024-5-22

Three-dimensional chromatin landscapes in MLLr AML

2024-5-22

Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer

2024-5-20

Analysis of CD20 and PD-L1 levels on small extracellular vesicles (sEV) produced by DLBCL cells and EBV-transformed B cells, and potential role in T cell inhibition

2024-5-17

Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer

2024-5-17

CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison

2024-5-14

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation

2024-5-11

Single-cell analysis defines highly specific leukemia-induced neutrophils and links MMP8 expression to recruitment of tumor associated neutrophils during FGFR1 driven leukemogenesis

2024-5-10

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice

2024-5-9

Enhanced cellular therapy: revolutionizing adoptive cellular therapy

2024-4-25

Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives

2024-4-23

Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways

2024-4-23

Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting

2024-4-22